Document Detail


Effects of Erythropoietin on Glucose Metabolism.
MedLine Citation:
PMID:  22351476     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
We purposed to determine the impact of erythropoietin on altering glucose metabolism in the settings of in vitro and in vivo experiments. The acute effect of erythropoietin on lowering blood glucose levels was studied in animal experiments. In [3H]-deoxy-d-glucose isotope studies we measured glucose uptake with insulin and erythropoietin using 3T3-L1 cells cultured under normal or high glucose conditions. Altered activation of Akt and ERK pathways was evaluated in immunoblot analyses. Immunocytochemistry was conducted to determine the glucose transporter 4 translocation to the plasma membrane. Addition of erythropoietin significantly lowered blood glucose levels in vivo in rats. The glucose uptake was markedly increased by erythropoietin treatment (at concentrations 0.15, 0.3, and 0.625 ng/ml) in adipocytes grown in high glucose medium (p<0.05), but it remained unaltered in cells under normal glucose conditions. Significant increase of phosphorylation of ERK and Akt was detected due to erythropoietin (p<0.05). Co-administration of erythropoietin and insulin resulted in higher phosphorylation of Akt and [3H]-deoxy-d-glucose uptake in adipocytes than insulin treatment alone. We found that erythropoietin induced the trafficking of glucose transporter 4 to the plasma membrane. Our data showed that erythropoietin significantly decreased blood glucose levels both in vivo and in vitro, in part, by increasing glucose uptake via the activation of Akt pathway. Preliminary data revealed that adipocytes most likely exhibit a specific receptor for erythropoietin.
Authors:
E Mikolás; J Cseh; M Pap; I A Szijárto; A Balogh; B Laczy; V Bekő; V Fisi; G A Molnár; A Mérei; J Szeberényi; I Wittmann
Related Documents :
8238506 - Progressive alterations in lipid and glucose metabolism during short-term fasting in yo...
1478616 - Venous versus arterialised venous blood for assessment of blood glucose levels during g...
22450556 - Type 2 diabetic patients and their offspring show altered parameters of iron status, ox...
2025856 - Insulin action and metabolism in patients with head and neck cancer.
20352346 - Vegf gene polymorphism association with diabetic neuropathy.
11818676 - Haemodialysis hypotension and nitric oxide production: comparison of heparin with parna...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-2-20
Journal Detail:
Title:  Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme     Volume:  -     ISSN:  1439-4286     ISO Abbreviation:  -     Publication Date:  2012 Feb 
Date Detail:
Created Date:  2012-2-21     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0177722     Medline TA:  Horm Metab Res     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© Georg Thieme Verlag KG Stuttgart · New York.
Affiliation:
2nd Department of Medicine and Nephrological Center, University of Pécs, Pécs, Hungary.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Reversed Glucose and Fatty Acids Transporter Expression in Human Endometrial Cancer.
Next Document:  Predictive Factors of Left Ventricular Mass Changes after Treatment of Primary Aldosteronism.